ArticleFrontiers in oncology2022

LCS-1 inhibition of superoxide dismutase 1 induces ROS-dependent death of glioma cells and degradates PARP and BRCA1.

Min Ling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.